D. S. Small

630 total citations
12 papers, 512 citations indexed

About

D. S. Small is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Surgery. According to data from OpenAlex, D. S. Small has authored 12 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pharmacology and 3 papers in Surgery. Recurrent topics in D. S. Small's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Inflammatory mediators and NSAID effects (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). D. S. Small is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Inflammatory mediators and NSAID effects (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). D. S. Small collaborates with scholars based in United States and United Kingdom. D. S. Small's co-authors include C. Steven Ernest, Nazar Farid, Christopher D. Payne, Daniel E. Salazar, Kenneth J. Winters, John T. Brandt, Joseph A. Jakubowski, Christelle Darstein, Diane Tang‐Liu and Rebecca E. Wrishko and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Journal of Thrombosis and Haemostasis and The Journal of Clinical Pharmacology.

In The Last Decade

D. S. Small

12 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. S. Small United States 8 397 157 109 103 89 12 512
Chiara Cattaruzzi Italy 6 135 0.3× 176 1.1× 191 1.8× 75 0.7× 75 0.8× 9 568
L Agostinis Italy 5 127 0.3× 170 1.1× 190 1.7× 71 0.7× 74 0.8× 7 550
Cheryle Gurk‐Turner United States 10 149 0.4× 165 1.1× 42 0.4× 35 0.3× 49 0.6× 18 613
Jean-Baptiste Estève France 6 677 1.7× 319 2.0× 196 1.8× 133 1.3× 192 2.2× 11 846
Paul A. Gurbel United States 14 526 1.3× 283 1.8× 77 0.7× 146 1.4× 80 0.9× 45 784
Seok‐Jae Hwang South Korea 16 581 1.5× 288 1.8× 87 0.8× 123 1.2× 114 1.3× 76 735
Yongwhi Park South Korea 22 1.2k 3.1× 699 4.5× 140 1.3× 265 2.6× 214 2.4× 108 1.5k
Glenn Carlson United States 15 289 0.7× 140 0.9× 46 0.4× 65 0.6× 95 1.1× 25 575
James W. Hainer United States 15 429 1.1× 147 0.9× 34 0.3× 148 1.4× 142 1.6× 23 722
Stephan Schmidt United States 8 211 0.5× 80 0.5× 34 0.3× 79 0.8× 41 0.5× 11 321

Countries citing papers authored by D. S. Small

Since Specialization
Citations

This map shows the geographic impact of D. S. Small's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. S. Small with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. S. Small more than expected).

Fields of papers citing papers by D. S. Small

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. S. Small. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. S. Small. The network helps show where D. S. Small may publish in the future.

Co-authorship network of co-authors of D. S. Small

This figure shows the co-authorship network connecting the top 25 collaborators of D. S. Small. A scholar is included among the top collaborators of D. S. Small based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. S. Small. D. S. Small is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zafar, M. Urooj, Carlos G. Santos‐Gallego, David Vorchheimer, et al.. (2012). Platelet function normalization after a prasugrel loading‐dose: time‐dependent effect of platelet supplementation. Journal of Thrombosis and Haemostasis. 11(1). 100–106. 44 indexed citations
2.
Small, D. S., Rebecca E. Wrishko, C. Steven Ernest, et al.. (2009). Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease. Journal of Clinical Pharmacy and Therapeutics. 34(5). 585–594. 61 indexed citations
3.
Small, D. S., Nazar Farid, C. Steven Ernest, et al.. (2009). Pharmacokinetics and pharmacodynamics of prasugrel in subjects with moderate liver disease. Journal of Clinical Pharmacy and Therapeutics. 34(5). 575–583. 23 indexed citations
4.
Farid, Nazar, Joseph A. Jakubowski, Christopher D. Payne, et al.. (2009). Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects. Current Medical Research and Opinion. 25(8). 1821–1829. 30 indexed citations
5.
Ernest, C. Steven, et al.. (2007). Prasugrel, a New Thienopyridine Antiplatelet Drug, Weakly Inhibits Cytochrome P450 2B6 in Humans. The Journal of Clinical Pharmacology. 48(1). 53–59. 47 indexed citations
6.
Farid, Nazar, Christopher D. Payne, D. S. Small, et al.. (2007). Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently. Clinical Pharmacology & Therapeutics. 81(5). 735–741. 248 indexed citations
7.
Derby, Michael A., Celedon Gonzales, Jill Chappell, et al.. (2005). QT interval analyses from a placebo and positive controlled study evaluating the electrophysiological effects of duloxetine at supratherapeutic doses. Clinical Pharmacology & Therapeutics. 77(2). P12–P12. 2 indexed citations
8.
Small, D. S., Corina Loghin, Ruth Lucas, et al.. (2005). Pharmacokinetic evaluation of combined duloxetine and fluvoxamine dosing in CYP2D6 poor metabolizers. Clinical Pharmacology & Therapeutics. 77(2). P37–P37. 7 indexed citations
9.
Derby, Michael A., Mary Gates, D. S. Small, & John T. Callaghan. (2005). A definitive QT study incorporating step-wise dose escalation to steady-state. Clinical Pharmacology & Therapeutics. 77(2). P12–P12. 2 indexed citations
10.
11.
Kent, Alexander R., et al.. (2000). BRIMONIDINE CONCENTRATIONS IN THE POSTERIOR SEGMENT OF PATIENTS DURING ALPHAGAN TREATMENT. Journal of Glaucoma. 9(1). 117–117. 3 indexed citations
12.
Small, D. S.. (1977). The first graduates of technical institute nursing courses: a follow-up.. PubMed. 70(11). 8–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Cattaruzzi Breakdown of academic impact, for papers by L Agostinis Breakdown of academic impact, for papers by Cheryle Gurk‐Turner Breakdown of academic impact, for papers by Jean-Baptiste Estève Breakdown of academic impact, for papers by Paul A. Gurbel Breakdown of academic impact, for papers by Seok‐Jae Hwang Breakdown of academic impact, for papers by Yongwhi Park Breakdown of academic impact, for papers by Glenn Carlson Breakdown of academic impact, for papers by James W. Hainer Breakdown of academic impact, for papers by Stephan Schmidt
Rankless by CCL
2026